Vetophage
PrivateLast Round
Early Funding
Jun 21, 2023
Company Overview
Vetophage is a biotechnology company that develops diagnostic tools and therapeutic solutions based on phages and phage proteins to combat antimicrobial resistance in animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vetophage Comparables
Compare Vetophage with similar companies based on industry and business-model similarity.
Vetophage Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 21, 2023 | ||||
| Seed | Nov 1, 2019 |
Vetophage Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Monthly visitors grew 135% MoM, reaching 1.4K.
- Jul 16, 2025
Grew 50% QoQ from 6 to 9 employees.
Vetophage Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vetophage's valuation, stock price, and market status.